Investor Update

Basel, 04 January 2016

Invitation to Roche's Full Year Results 2015

Roche will publish its Full Year Results for 2015 prior to the opening of the Swiss Stock Exchange on Thursday, 28 January 2016.

7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)

Release will be e-mailed and posted on the Roche IR website click here.

Presentation slides will be posted on the Roche IR website click here.

We would like to invite all interested parties to participate or dial in to the event outlined below.

Thursday, 28 January 2016, London

The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the London Stock Exchange, The Theatre, 10 Paternoster Square, London EC4M 7LS map


  • Severin Schwan, CEO Roche Group
  • Alan Hippe, Chief Financial and IT Officer
  • Daniel O'Day, COO Pharmaceuticals
  • Roland Diggelmann, COO Diagnostics

Meeting information:

Download to my calendar

Date: 28 January 2016

Time (GMT):
14:30 Registration
15:00 Meeting starts
17:30 Meeting ends, followed by a buffet reception

Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.

Following the event we would also like to invite you to drinks and canap├ęs to give you the opportunity to speak to management more informally.

Please make sure you have identification and allow enough time to go through the London Stock Exchange security check.

To register for the event, please follow the link

This presentation can also be accessed through a live video webcast:

Alternatively, you may dial in to the conference, using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)

To expedite the registration process on the day of the event, you may pre-register for the conference call. click here.


A replay will be available following the event, for 48 hours. Access is by dialing:
+41 (0) 91 612 4330 (Europe and ROW) or
+44 (0) 207 108 6233 (UK) or
+1 (1) 631 982 4566 (USA)

Please enter the conference ID 13785 followed by the # sign.

A replay of the video webcast will be available on demand on the Roche website. click here.